Dataset Information

Patients' perspectives on electroconvulsive therapy: systematic review.

ABSTRACT: OBJECTIVE:To ascertain patients' views on the benefits of and possible memory loss from electroconvulsive therapy. DESIGN:Descriptive systematic review. DATA SOURCES:Psychinfo, Medline, Web of Science, and Social Science Citation Index databases, and bibliographies. STUDY SELECTION:Articles with patients' views after treatment with electroconvulsive therapy. DATA EXTRACTION:26 studies carried out by clinicians and nine reports of work undertaken by patients or with the collaboration of patients were identified; 16 studies investigated the perceived benefit of electroconvulsive therapy and seven met criteria for investigating memory loss. DATA SYNTHESIS:The studies showed heterogeneity. The methods used were associated with levels of perceived benefit. At least one third of patients reported persistent memory loss. CONCLUSIONS:The current statement for patients from the Royal College of Psychiatrists that over 80% of patients are satisfied with electroconvulsive therapy and that memory loss is not clinically important is unfounded.

SUBMITTER: Rose D

PROVIDER: S-EPMC162130 | biostudies-literature | 2003 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Patients' perspectives on electroconvulsive therapy: systematic review.

Rose Diana D Fleischmann Pete P Wykes Til T Leese Morven M Bindman Jonathan J

BMJ (Clinical research ed.) 20030601 7403

<h4>Objective</h4>To ascertain patients' views on the benefits of and possible memory loss from electroconvulsive therapy.<h4>Design</h4>Descriptive systematic review.<h4>Data sources</h4>Psychinfo, Medline, Web of Science, and Social Science Citation Index databases, and bibliographies.<h4>Study selection</h4>Articles with patients' views after treatment with electroconvulsive therapy.<h4>Data extraction</h4>26 studies carried out by clinicians and nine reports of work undertaken by patients or ...[more]

PMID: 12816822

Similar Datasets

Project description:ObjectiveThe primary indication for electroconvulsive therapy is medication-resistant major depression. There is some evidence that combining electroconvulsive therapy with an antidepressant, instead of electroconvulsive therapy monotherapy, might improve remission rates. However, data on this topic have not been systematically studied. We undertook a systematic review and meta-analysis to determine the effectiveness of an adjuvant antidepressant during electroconvulsive therapy for major depression.MethodsEmbase, Medline Ovid, Web of Science, Cochrane Central, PsychINFO Ovid and Google Scholar were searched up to January 2019. Randomized controlled trials and cohort studies reporting on the influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy for major depression were included. Authors independently screened records, extracted data and assessed study quality. We reported this systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.ResultsNine studies were included in the meta-analysis. The meta-analysis revealed a significant advantage of adjuvant antidepressants versus placebo. The overall effect size per category of antidepressant was as follows: tricyclic antidepressants: Hedges' g 0.32 (95% confidence interval: [0.14, 0.51]) (k = 6) with low heterogeneity (I2: 4%, p = 0.39); selective serotonin reuptake inhibitors/serotonin noradrenaline reuptake inhibitors: Hedges' g 0.27 (95% confidence interval: [0.03, 0.52]) (k = 2) with a lack of heterogeneity (I2: 0%, p = 0.89); and monoamine oxidase inhibitors: Hedges' g 0.35 (95% confidence interval: [-0.07, 0.77]) with moderate heterogeneity (I2: 43%, p = 0.17) (k = 3).ConclusionAn adjuvant antidepressant enhances the efficacy of electroconvulsive therapy for major depression. Tricyclic antidepressants, selective serotonin reuptake inhibitors/serotonin noradrenaline reuptake inhibitors and monoamine oxidase inhibitors showed the same effect size. However, the effect sizes of tricyclic antidepressants and monoamine oxidase inhibitors are most likely underestimated, due to insufficient doses in most of the included studies. We recommend the routine use of an adequately dosed antidepressant during electroconvulsive therapy for major depression.

Dataset Information

Patients' perspectives on electroconvulsive therapy: systematic review.

Publications

Patients' perspectives on electroconvulsive therapy: systematic review.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets